tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Company (TAK)
:TAK
US Market

Takeda Pharmaceutical Company (TAK) Income Statement

Compare
1,332 Followers

Takeda Pharmaceutical Company Income Statement

Last quarter (Q2 2025), Takeda Pharmaceutical Company's total revenue was ¥1.11T, a decrease of -5.38% from the same quarter last year. In Q2, Takeda Pharmaceutical Company's net income was ¥-11.80B. See Takeda Pharmaceutical Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit
¥ 3.00T¥ 2.83T¥ 2.78T¥ 2.46T¥ 2.20T
Operating Expenses
¥ 2.66T¥ 2.62T¥ 2.29T¥ 2.00T¥ 1.69T
Depreciation and Amortization
¥ 761.40B¥ 644.46B¥ 664.40B¥ 583.15B¥ 559.67B
EBITDA
¥ 1.21T¥ 1.14T¥ 1.28T¥ 1.18T¥ 983.72B
Operating Income
¥ 342.59B¥ 214.07B¥ 490.50B¥ 460.84B¥ 509.27B
Other Income/Expenses
¥ -167.50B¥ -161.28B¥ -115.42B¥ -158.27B¥ -143.03B
Pretax Income
¥ 175.08B¥ 52.79B¥ 375.09B¥ 302.57B¥ 366.24B
Net Income
¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Per Share Metrics
Basic EPS
¥ 34.17¥ 46.05¥ 102.15¥ 73.57¥ 120.36
Diluted EPS
¥ 33.62¥ 45.58¥ 100.97¥ 72.94¥ 119.48
Weighted Average Shares Outstanding
3.21B 3.13B 3.10B 3.13B 3.12B
Weighted Average Shares Outstanding (Diluted)
3.21B 3.16B 3.14B 3.15B 3.15B
Currency in JPY

Takeda Pharmaceutical Company Earnings and Revenue History